KAITLAND SHUSTER: Open Payments
NPI 1215459359 · NORTH HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,164 in 143 payments from 11 companies in 2025. Trend: 2023 $4,811 · 2024 $6,681 · 2025 $7,164
Speaker / faculty: $5,000Food & beverage: $2,119Travel & lodging: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 94 | $6,350 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $219 |
| Teva Pharmaceuticals USA, Inc. | 9 | $143 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 5 | $85 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Alkermes, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, UZEDY, Jornay PM, ARISTADA.
Industry payments across PA — which companies pay providers there.
